| Genetically distinct subsets within ANCA-associated vasculitis PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ... New England Journal of Medicine 367 (3), 214-223, 2012 | 1064 | 2012 |
| KDIGO 2021 clinical practice guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), S1-S276, 2021 | 808 | 2021 |
| Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), 753-779, 2021 | 410 | 2021 |
| Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19 C Bredrup, S Saunier, MM Oud, T Fiskerstrand, A Hoischen, D Brackman, ... The American Journal of Human Genetics 89 (5), 634-643, 2011 | 257 | 2011 |
| Ischemia and reperfusion injury in kidney transplantation: relevant mechanisms in injury and repair GJ Nieuwenhuijs-Moeke, SE Pischke, SP Berger, JSF Sanders, RA Pol, ... Journal of clinical medicine 9 (1), 253, 2020 | 197 | 2020 |
| Accelerated atherosclerosis in patients with Wegener’s granulomatosis K de Leeuw, JS Sanders, C Stegeman, A Smit, CG Kallenberg, M Bijl Annals of the rheumatic diseases 64 (5), 753-759, 2005 | 193 | 2005 |
| Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment JSF Sanders, MG Huitma, CGM Kallenberg, CA Stegeman Rheumatology 45 (6), 724-729, 2006 | 188 | 2006 |
| Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis AAE de Joode, JSF Sanders, CA Stegeman Clinical Journal of the American Society of Nephrology 8 (10), 1709-1717, 2013 | 180 | 2013 |
| Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis FWK Tam, JS Sanders, A George, T Hammad, C Miller, T Dougan, ... Nephrology Dialysis Transplantation 19 (11), 2761-2768, 2004 | 152 | 2004 |
| The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821-834, 2022 | 140 | 2022 |
| Urinary soluble CD163 in active renal vasculitis VP O’Reilly, L Wong, C Kennedy, LA Elliot, S O’Meachair, AM Coughlan, ... Journal of the American Society of Nephrology 27 (9), 2906-2916, 2016 | 127 | 2016 |
| Effect of CYP3A4* 22, CYP3A5* 3, and CYP3A combined genotypes on cyclosporine, everolimus, and tacrolimus pharmacokinetics in renal transplantation D Moes, JJ Swen, J Den Hartigh, T Van Der Straaten, JJH van der Heide, ... CPT: pharmacometrics & systems pharmacology 3 (2), 1-12, 2014 | 95 | 2014 |
| Early conversion from calcineurin inhibitor‐to everolimus‐based therapy following kidney transplantation: results of the randomized ELEVATE trial JW de Fijter, H Holdaas, O Øyen, JS Sanders, S Sundar, FJ Bemelman, ... American Journal of Transplantation 17 (7), 1853-1867, 2017 | 87 | 2017 |
| Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis … JSF Sanders, MG Huitma, CGM Kallenberg, CA Stegeman Annals of the rheumatic diseases 65 (11), 1484-1489, 2006 | 87 | 2006 |
| Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis PM Stassen, JSF Sanders, CGM Kallenberg, CA Stegeman Nephrology Dialysis Transplantation 23 (2), 654-658, 2008 | 86 | 2008 |
| HDL cholesterol efflux predicts graft failure in renal transplant recipients W Annema, A Dikkers, JF de Boer, RPF Dullaart, JSF Sanders, ... Journal of the American Society of Nephrology 27 (2), 595-603, 2016 | 80 | 2016 |
| Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis JSF Sanders, H Van Goor, R Hanemaaijer, CGM Kallenberg, ... Nephrology Dialysis Transplantation 19 (6), 1412-1419, 2004 | 80 | 2004 |
| Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain … JSF Sanders, AAE De Joode, RG DeSevaux, J Broekroelofs, AE Voskuyl, ... Nephrology Dialysis Transplantation 31 (9), 1453-1459, 2016 | 76 | 2016 |
| What is the current evidence for disease subsets in giant cell arteritis? KSM van der Geest, M Sandovici, Y van Sleen, JS Sanders, NA Bos, ... Arthritis & rheumatology 70 (9), 1366-1376, 2018 | 71 | 2018 |
| Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant EG Kamburova, BW Wisse, I Joosten, WA Allebes, A Van Der Meer, ... American Journal of Transplantation 18 (9), 2274-2284, 2018 | 68 | 2018 |
